Ticagrelor (BRILINTA)

{x}Pharmacological Category: Platelet aggregation inhibitor
{x}MOA: Reversibly & Noncompetitively binds adenosine diphospate (ADP) P2y12 on platlet surface prevents activation of GP11b/111a receptor.
{b}{b}{b} BLACK BOX WARNING: Rx ^ risk of bleeding including significant & sometimes fatal bleeding
{b}Adverse Effects >10% respiratory dyspnea
{ut}Indications: Acute Coronary Syndrome